News
-
-
COMMUNIQUÉ DE PRESSE
Gemina Laboratories Sign First Strategic License Agreement
Gemina Laboratories Ltd. announces license agreement with global diagnostics company, validating its technology in the in vitro diagnostics market. CEO Brian Firth highlights cost-saving potential and future partnerships -
COMMUNIQUÉ DE PRESSE
Repair Biotechnologies Demonstrates Rapid Reversal of Atherosclerosis in Mouse Models
Repair Biotechnologies announced positive results in reversing atherosclerosis & preparing for FDA meetings. Their LNP/mRNA therapy shows promise for treating familial hypercholesterolemia & metabolic dysfunction -
-
-
COMMUNIQUÉ DE PRESSE
Suralink Announces Accreditation With Institute of Chartered Accountants in England and Wales (ICAEW)
Suralink obtains accreditation with ICAEW, strengthening its position in request list management software space. The accreditation promotes inclusivity, diversity and fairness in chartered accounting -
COMMUNIQUÉ DE PRESSE
Emmis Capital Launches $10 Million Reg D Capital Raise Using the tZERO Securities Services
tZERO Group Inc. launches Emmis Capital's fund capital raise, offering investment opportunities in pre-IPO, IPO, and emerging growth companies on major exchanges through tZERO Securities, a regulated broker-dealer -
-
COMMUNIQUÉ DE PRESSE
Jaguar Health Appoints European Pharmaceutical Industry Leader as President of Jaguar International
Dr. Massimo Radaelli appointed as President of Jaguar International to expand commercial footprint globally with recent out-license agreement. Key pharmaceutical industry leader with vast experience and expertise -
COMMUNIQUÉ DE PRESSE
Original-Research: PNE AG (von First Berlin Equity Research GmbH): Buy
First Berlin Equity Research GmbH releases a research update on PNE AG, reiterating a Buy rating with a target price of EUR 21.00. The update highlights PNE's strong EBITDA growth and expanding wind power portfolio
